Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin P Dinney

Showing results (101-110 of 202) with videos related to

Pageof 21
Sort By:
Neoplasia (New York, N.Y.)|October 26, 2005
The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumorsKhalid A Mohamedali, Daniel Kedar, Paul Sweeney, et al.
Surgery|January 14, 2017
Generation of patient-derived xenografts from fine needle aspirates or core needle biopsyDavid Roife, Ya'an Kang, Li Wang, et al.
Urologic Oncology|December 14, 2020
Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost driversJanet Baack Kukreja, Mohamed A Seif, Marissa W Mery, et al.
The Journal of Urology|October 17, 2022
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not TherapeuticKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|May 22, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. ReplyKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|July 13, 2004
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experienceArlene O Siefker-Radtke, Colin P Dinney, Neil A Abrahams, et al.
Urology|September 18, 2009
Cardiac history and risk of post-cystectomy cardiac complicationsMark B Fisher, Robert S Svatek, Paul K Hegarty, et al.
Carcinogenesis|June 10, 2010
Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patientsMeng Chen, Jian Gu, George L Delclos, et al.
American Journal of Human Genetics|February 9, 2006
Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genesXifeng Wu, Jian Gu, H Barton Grossman, et al.
European Urology Oncology|August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical CystectomyRoberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
Pageof 21

Showing results (101-110 of 202) with videos related to

Sort By:
Pageof 21
Neoplasia (New York, N.Y.)|October 26, 2005
The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumorsKhalid A Mohamedali, Daniel Kedar, Paul Sweeney, et al.
Surgery|January 14, 2017
Generation of patient-derived xenografts from fine needle aspirates or core needle biopsyDavid Roife, Ya'an Kang, Li Wang, et al.
Urologic Oncology|December 14, 2020
Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost driversJanet Baack Kukreja, Mohamed A Seif, Marissa W Mery, et al.
The Journal of Urology|October 17, 2022
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not TherapeuticKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|May 22, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. ReplyKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|July 13, 2004
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experienceArlene O Siefker-Radtke, Colin P Dinney, Neil A Abrahams, et al.
Urology|September 18, 2009
Cardiac history and risk of post-cystectomy cardiac complicationsMark B Fisher, Robert S Svatek, Paul K Hegarty, et al.
Carcinogenesis|June 10, 2010
Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patientsMeng Chen, Jian Gu, George L Delclos, et al.
American Journal of Human Genetics|February 9, 2006
Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genesXifeng Wu, Jian Gu, H Barton Grossman, et al.
European Urology Oncology|August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical CystectomyRoberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
Pageof 21